Evidence map›Paper›PMID 33165947›Full record

ArticleAnnals of the New York Academy of Sciences2020

Assessment of mustard vesicant lung injury and anti-TNF-α efficacy in rodents using live-animal imaging.

Alexa Murray, Andrew J Gow, Alessandro Venosa, Jaclynn Andres, Rama Malaviya, Derek Adler, Edward Yurkow, Jeffrey D Laskin, Debra L Laskin

Open access · greenAbstract read
In one paragraph

Article in Annals of the New York Academy of Sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes.Drug metabolism and disposition: the biological fate of chemicals · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alexa MurrayDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey.ORCID 0000-0001-6133-6710
Andrew J GowDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey.ORCID 0000-0003-0876-5158
Alessandro VenosaDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah.ORCID 0000-0003-3741-2634
Jaclynn AndresDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey.ORCID 0000-0002-1491-3594
Rama MalaviyaDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey.ORCID 0000-0002-3818-1594
Derek AdlerMolecular Imaging Center, Rutgers University, Piscataway, New Jersey.
Edward YurkowMolecular Imaging Center, Rutgers University, Piscataway, New Jersey.ORCID 0000-0001-8773-9729
Jeffrey D LaskinDepartment of Environmental and Occupational Health, School of Public Health, Rutgers University, Piscataway, New Jersey.
Debra L LaskinDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey.ORCID 0000-0003-1832-7311
Rutgers, The State University of New Jersey · USUniversity of Utah · US

Funding

UMDNJ/Rutgers University CounterACT Research Center of ExcellenceU54AR055073 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LASKIN, JEFFREY D · 2006 to 2024
$71.4M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
TRAINING IN EVIRONMENTAL TOXICOLOGYT32ES007148 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Lauren M Aleksunes · 1987 to 2026
$11.4M
ACTIVATED MACROPHAGES AND OZONE TOXICITYR01ES004738 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Debra L Laskin · 1989 to 2026
$9.0M
NO-Modified Biomolecules and Pulmonary SignalingR01HL086621 · NHLBI · RUTGERS, THE STATE UNIV OF N.J. · PI GOW, ANDREW J · 2008 to 2016
$2.8M
Ozone, inflammation and respiratory microbiomeR21ES029254 · NIEHS · RUTGERS, THE STATE UNIV OF N.J. · PI GOW, ANDREW J · 2018 to 2019
$426k
NHLBI NIH HHS R01 HL086621NHLBI NIH HHS R01HL086621NIAMS NIH HHS U54 AR055073NIAMS NIH HHS U54AR055073NIEHS NIH HHS P30 ES005022NIEHS NIH HHS P30ES005022NIEHS NIH HHS R01 ES004738NIEHS NIH HHS R01ES004738NIEHS NIH HHS R21 ES029254NIEHS NIH HHS R21ES029254NIEHS NIH HHS T32 ES007148NIEHS NIH HHS T32ES007148
6 · The paper itself

Abstract

Nitrogen mustard (NM) causes acute lung injury, which progresses to fibrosis. This is associated with a macrophage-dominant inflammatory response and the production of proinflammatory/profibrotic mediators, including tumor necrosis factor alpha (TNF-α). Herein, we refined magnetic resonance imaging (MRI) and computed tomography (CT) imaging methodologies to track the progression of NM-induced lung injury in rodents and assess the efficacy of anti-TNF-α antibody in mitigating toxicity. Anti-TNF-α antibody was administered to rats (15 mg/kg, every 8 days, intravenously) beginning 30 min after treatment with phosphate-buffered saline control or NM (0.125 mg/kg, intratracheally). Animals were imaged by MRI and CT prior to exposure and 1-28 days postexposure. Using MRI, we characterized acute lung injury and fibrosis by quantifying high-signal lung volume, which represents edema, inflammation, and tissue consolidation; these pathologies were found to persist for 28 days following NM exposure. CT scans were used to assess structural components of the lung and to register changes in tissue radiodensities. CT scans showed that in control animals, total lung volume increased with time. Treatment of rats with NM caused loss of lung volume; anti-TNF-α antibody mitigated this decrease. These studies demonstrate that MRI and CT can be used to monitor lung disease and the impact of therapeutic intervention.

Indexed as

Acute Lung InjuryMagnetic Resonance ImagingPulmonary FibrosisTomography, X-Ray ComputedAnimalsAntibodies, Monoclonal, Murine-DerivedIrritantsMaleMechlorethamineRatsTime FactorsTumor Necrosis Factor-alphaAntibodies, Monoclonal, Murine-DerivedIrritantsMechlorethamineTumor Necrosis Factor-alphaacute lung injuryCTlungMRImustard vesicantsTNF-α

Identifiers

PMID33165947
PMCPMC7968421
OpenAlexW3098243090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.